Advanced Oncotherapy raises £5.9m to progress LIGHT system

Advanced Oncotherapy CEO Nicolas Serandour

Proton beam therapy specialist Advanced Oncotherapy (AVO) has raised £5.9m through a placing and subscription for 14.8m shares at 40p per share. The move follows a £7.7m…

You must be a HM Subscriber to view this content.

Subscribe Now »